×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ANNX – annexon, inc. - common stock (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ANNX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/17
08:15 am
annx
Annexon, Inc. (NASDAQ: ANNX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Medium
Report
Annexon, Inc. (NASDAQ: ANNX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
12/16
04:05 pm
annx
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
12/16
07:47 am
annx
Annexon Announces Positive Topline Results from Real-World Evidence Study Comparing ANX005 Treatment to Intravenous Immunoglobulin (IVIg) or Plasma Exchange (PE) in a Matched Patient Cohort for the Treatment of Guillain-Barré Syndrome (GBS) [Yahoo! Financ
Low
Report
Annexon Announces Positive Topline Results from Real-World Evidence Study Comparing ANX005 Treatment to Intravenous Immunoglobulin (IVIg) or Plasma Exchange (PE) in a Matched Patient Cohort for the Treatment of Guillain-Barré Syndrome (GBS) [Yahoo! Financ
12/16
07:30 am
annx
Annexon Announces Positive Topline Results from Real-World Evidence Study Comparing ANX005 Treatment to Intravenous Immunoglobulin (IVIg) or Plasma Exchange (PE) in a Matched Patient Cohort for the Treatment of Guillain-Barré Syndrome (GBS)
High
Report
Annexon Announces Positive Topline Results from Real-World Evidence Study Comparing ANX005 Treatment to Intravenous Immunoglobulin (IVIg) or Plasma Exchange (PE) in a Matched Patient Cohort for the Treatment of Guillain-Barré Syndrome (GBS)
12/5
08:10 am
annx
Annexon to Present Phase 2 ARCHER Data on Protection of Vision and Photoreceptors with ANX007 in Geographic Atrophy at the Floretina-ICOOR 2024 Meeting [Yahoo! Finance]
Medium
Report
Annexon to Present Phase 2 ARCHER Data on Protection of Vision and Photoreceptors with ANX007 in Geographic Atrophy at the Floretina-ICOOR 2024 Meeting [Yahoo! Finance]
12/5
08:00 am
annx
Annexon to Present Phase 2 ARCHER Data on Protection of Vision and Photoreceptors with ANX007 in Geographic Atrophy at the Floretina-ICOOR 2024 Meeting
Medium
Report
Annexon to Present Phase 2 ARCHER Data on Protection of Vision and Photoreceptors with ANX007 in Geographic Atrophy at the Floretina-ICOOR 2024 Meeting
11/15
05:15 pm
annx
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
High
Report
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
11/15
04:59 pm
annx
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
High
Report
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
Date
Time
Symbol
Company Name
Action
%Chg
11/14/2024
08:00 am
annx
annexon, inc. - common stock
BEAT
Report
-7.9%
annexon, inc. - common stock
8/12/2024
08:00 am
annx
annexon, inc. - common stock
IN-LINE
Report
2.4%
annexon, inc. - common stock
5/13/2024
08:00 am
annx
annexon, inc. - common stock
BEAT
Report
-0.6%
annexon, inc. - common stock
3/26/2024
04:05 pm
annx
annexon, inc. - common stock
BEAT
Report
13.5%
annexon, inc. - common stock
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/16
07:47 am
annx
Form 8-K Annexon, Inc. For: Dec 16
Medium
Report
Form 8-K Annexon, Inc. For: Dec 16
12/6
11:27 am
annx
Form SCHEDULE 13G/A Annexon, Inc. Filed by: FMR LLC
Low
Report
Form SCHEDULE 13G/A Annexon, Inc. Filed by: FMR LLC
12/4
06:13 pm
annx
Form 4 Annexon, Inc. For: Dec 02 Filed by: Carson William H.
Medium
Report
Form 4 Annexon, Inc. For: Dec 02 Filed by: Carson William H.
11/14
07:22 pm
annx
Form SC 13G/A Annexon, Inc. Filed by: BB BIOTECH AG
High
Report
Form SC 13G/A Annexon, Inc. Filed by: BB BIOTECH AG
11/14
06:47 pm
annx
Form SC 13G/A Annexon, Inc. Filed by: Logos Global Management LP
High
Report
Form SC 13G/A Annexon, Inc. Filed by: Logos Global Management LP
11/14
05:31 pm
annx
Form SC 13G/A Annexon, Inc. Filed by: Bain Capital Life Sciences Fund, L.P.
High
Report
Form SC 13G/A Annexon, Inc. Filed by: Bain Capital Life Sciences Fund, L.P.
11/14
04:37 pm
annx
Form SC 13G/A Annexon, Inc. Filed by: BIOTECHNOLOGY VALUE FUND L P
Medium
Report
Form SC 13G/A Annexon, Inc. Filed by: BIOTECHNOLOGY VALUE FUND L P
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: